Edwards Lifesciences To Present At The Roth Capital Partners 18th Annual OC Conference
Published: Feb 16, 2006
IRVINE, Calif., Feb. 16 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation , a global leader in medical technologies to treat advanced cardiovascular disease, is scheduled to participate in the Roth Capital Partners 18th Annual OC Conference at the St. Regis Monarch Beach Resort & Spa in Dana Point, Calif., on February 21, 2006.
Larry L. Wood, Edwards Lifesciences' vice president, general manager of Percutaneous Valve Interventions -- Valve Replacement, will speak to the attendees of the conference that day at 9:30 a.m. PST. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences' investor relations website at http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards' investor relations website in the News and Events section.
About Edwards Lifesciences
Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT and Swan-Ganz. Additional company information can be found at http://www.edwards.com.
Edwards Lifesciences, Edwards, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and
are registered in the U.S. Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the U.S. Patent and Trademark Office. FloTrac is a trademark of Edwards Lifesciences Corporation.Edwards Lifesciences Corporation
CONTACT: Investors, David K. Erickson, +1-949-250-6826, or Media, Barry R.Liden, +1-949-250-5070, both of Edwards Lifesciences Corporation